Literature DB >> 11234759

Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.

M Cyr1, M Morissette, M Landry, T Di Paolo.   

Abstract

We have previously shown in rats that estradiol has brain regionally specific effects on AMPA receptors. The present study investigated hormonal specificity of AMPA receptors by comparing the effect of estradiol with tamoxifen or raloxifene, which have varying effects on estrogen response in breast, bone and uterus. Ovariectomy in rats decreased uterus weight which was restored by estradiol treatment, whereas tamoxifen and raloxifene had only a weak effect. Ovariectomy left unchanged AMPA receptor specific binding in rat brain whereas estradiol, tamoxifen and raloxifene decreased it in cortical and striatal regions of ovariectomized rats. Hence, tamoxifen and raloxifene showed agonist estrogenic activity on AMPA receptors in specific brain regions, which can be dissociated from their antagonist estrogenic activity in the periphery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11234759     DOI: 10.1097/00001756-200103050-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats.

Authors:  Alicia A Walf; Cheryl Anne Frye
Journal:  Behav Pharmacol       Date:  2010-05       Impact factor: 2.293

Review 3.  Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.

Authors:  Stephanie Murphy; Louise McCullough; Marguerite Littleton-Kearney; Patricia Hurn
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

4.  Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?

Authors:  Krishnan Dhandapani; Darrell Brann
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

5.  Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women.

Authors:  Paul Newhouse; Kimberly Albert; Robert Astur; Julia Johnson; Magdalena Naylor; Julie Dumas
Journal:  Neuropsychopharmacology       Date:  2013-07-19       Impact factor: 7.853

Review 6.  Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.

Authors:  Leo Veenman
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

Review 7.  Sex differences in vulnerability to addiction.

Authors:  Jacqueline A Quigley; Molly K Logsdon; Christopher A Turner; Ivette L Gonzalez; N B Leonardo; Jill B Becker
Journal:  Neuropharmacology       Date:  2021-02-07       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.